US Underuse of GLP-1RA, SGLT-2i in Type 2 Diabetes Persists
A large, US study found that just 1 in 8 patients with type 2 diabetes received first-line medications for comorbid atherosclerotic cardiovascular disease, heart failure, and diabetic nephropathy.
First Look
source https://www.medscape.com/viewarticle/968488?src=rss
First Look
source https://www.medscape.com/viewarticle/968488?src=rss
Comments
Post a Comment